How is Xelma® different from other wound therapies?

Home > The Evidence >

FAQs

How is Xelma different from other wound therapies?

Xelma® is the first product containing extracellular matrix protein, amelogenin, which temporarily replaces the damaged extracellular matrix proteins in hard-to-heal wounds in order to restore wound healing.

FAQs: Venous leg ulcers (908kb) | Diabetic foot ulcers (797kb)

	How Xelma works When applied to the wound bed Xelma restores the damaged proteins providing an extracellular matrix protien for cell attachment. FIND OUT MORE

	What is the extracellular matrix? The extracellular matrix (ECM) plays and important role in the wound healing process. It acts as a scaffold within the wound, providing a framework to which cells can attach, proliferate and synthesise... FIND OUT MORE

	How to use Xelma Xelma is indicated for hard-to-heal ulcers - primarliy, venous leg ulcers. Xelma can be used under compression therapy. FIND OUT MORE!

XELMA UPDATES Confirmed efficacy of Xelma in the treatment of hard-to-heal wounds offers new hope for patients and clinicians. New algorithm for the management of hard-to-heal venous leg ulcers.

XELMA UPDATES

Confirmed efficacy of Xelma in the treatment of hard-to-heal wounds offers new hope for patients and clinicians.

New algorithm for the management of hard-to-heal venous leg ulcers.

Build: 1.0.1.1 (6/3/2010 9:48:03 AM)

FAQs

How is Xelma different from other wound therapies?

How Xelma works

What is the extracellular matrix?

How to use Xelma

XELMA UPDATES